InnovAge profit margin INNV
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- −0.3%
- Operating margin, 12 months
- 0.3%
- Net margin on a year earlier
- +3.3 pts
- Peer median
- 5.0%
Over the twelve months to Jun 30, 2026, InnovAge kept −0.3% of its revenue as net profit, with an operating margin of 0.3%.
Five years earlier its net margin was −6.9%.
The median for 10 hospital and care facility stocks of a similar size is 5.0%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin |
|---|---|---|
| FY2026 | −0.3% | 0.3% |
| FY2025 | −3.6% | −3.5% |
| FY2024 | −2.8% | −3.0% |
| FY2023 | −5.9% | −7.2% |
| FY2022 | −0.9% | −0.6% |
| FY2021 | −6.9% | −1.9% |
| FY2020 | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q4 FY26 | −0.3% | +3.3 pts | 0.3% | |
| Q3 FY26 | −1.2% | +2.5 pts | −1.0% | |
| Q2 FY26 | 0.7% | +3.9 pts | 1.0% | |
| Q1 FY26 | −2.0% | +0.1 pts | −1.9% | |
| Q4 FY25 | −3.6% | −0.8 pts | −3.5% | |
| Q3 FY25 | −3.8% | +0.4 pts | −3.9% | |
| Q2 FY25 | −3.2% | +1.2 pts | −3.5% | |
| Q1 FY25 | −2.0% | +3.4 pts | −2.2% | |
| Q4 FY24 | −2.8% | +3.1 pts | −3.0% | |
| Q3 FY24 | −4.2% | +2.0 pts | −3.9% | |
| Q2 FY24 | −4.4% | +1.2 pts | −4.4% | |
| Q1 FY24 | −5.4% | −1.5 pts | −6.2% |
Against its peers
Companies in Medical - Care Facilities nearest InnovAge's size, closest first, today.
| Company | Profit margin |
|---|---|
| INNVInnovAge | −0.3% |
| USPHU S Physical Therapy | 4.0% |
| PNTGPennant | 2.9% |
| OMDAOmada Health | 1.4% |
| ARDTArdent Health | 1.2% |
| HCSGHealthcare Services | 6.6% |
| PGNYProgyny | 6.0% |
| ADUSAddus HomeCare | 7.1% |
| MDPediatrix Medical | 9.0% |
| PRVAPrivia Health | 1.2% |
| AVAHAveanna Healthcare | 10.6% |
| Peer median | 5.0% |
Where InnovAge ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on InnovAge
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.